Literature DB >> 15526361

Effect of hepatoma H22 on lymphatic endothelium in vitro.

Hua Yu1, Hong-Zhi Zhou, Chun-Mei Wang, Xiao-Ming Gu, Bo-Rong Pan.   

Abstract

AIM: To determine the effect of metastatic hepatoma cells on lymphangioma-derived endothelium, and to establish in vitro model systems for assessing metastasis-related response of lymphatic endothelium.
METHODS: Benign lymphangioma, induced by intraperitoneal injection of the incomplete Freund's adjuvant in BALB/c mice, was embedded in fibrin gel or digested and then cultured in the conditioned medium derived from hepatoma H22. Light and electron microscopy, and the transwell migration assay were used to determine the effect of H22 on tissue or cell culture. Expressions of Flt-4, c-Fos, proliferating cell nuclear antigen (PCNA), and inducible nitric oxide synthase (iNOS) in cultured cells, and content of nitric oxide in culture medium were also examined.
RESULTS: The embedded lymphangioma pieces gave rise to array of capillaries, while separated cells from lymphangioma grew to a cobblestone-like monolayer. H22 activated growth and migration of the capillaries and cells, induced expressions of Flt-4, c-Fos, PCNA and iNOS in cultured cells, and significantly increased the content of NO in the culture medium.
CONCLUSION: Lymphangioma-derived cells keep the differentiated phenotypes of lymphatic endothelium, and the models established in this study are feasible for in vitro study of metastasis-related response of lymphatic endothelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526361      PMCID: PMC4576223          DOI: 10.3748/wjg.v10.i23.3428

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.

Authors:  Joseph S Palumbo; Jill M Potter; Lisa S Kaplan; Kathryn Talmage; David G Jackson; Jay L Degen
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  Angiogenesis assays: a critical overview.

Authors:  Robert Auerbach; Rachel Lewis; Brenda Shinners; Louis Kubai; Nasim Akhtar
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

3.  Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan.

Authors:  R Deed; P Rooney; P Kumar; J D Norton; J Smith; A J Freemont; S Kumar
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

4.  Histochemical analysis of lymphatic endothelial cells in lymphostasis.

Authors:  R C Ji; S Kato
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

5.  B16-BL6 melanoma cells release inhibitory factor(s) of active pump activity in isolated lymph vessels.

Authors:  K Nakaya; R Mizuno; T Ohhashi
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

6.  Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins.

Authors:  R Mizuno; A Koller; G Kaley
Journal:  Am J Physiol       Date:  1998-03

7.  Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.

Authors:  B Enholm; T Karpanen; M Jeltsch; H Kubo; F Stenback; R Prevo; D G Jackson; S Yla-Herttuala; K Alitalo
Journal:  Circ Res       Date:  2001-03-30       Impact factor: 17.367

Review 8.  Insights into the mechanisms of lymph node metastasis.

Authors:  S David Nathanson
Journal:  Cancer       Date:  2003-07-15       Impact factor: 6.860

Review 9.  Molecular targeting of lymphatics for therapy.

Authors:  S A Stacker; R A Hughes; M G Achen
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 10.  Lymphatic endothelium: morphological, molecular and functional properties.

Authors:  Michael S Pepper; Mihaela Skobe
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.